395 related articles for article (PubMed ID: 25831421)
1. Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States.
Mast TC; Wang FT; Su S; Seeger JD
Pediatr Infect Dis J; 2015 Jun; 34(6):615-20. PubMed ID: 25831421
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
[TBL] [Abstract][Full Text] [Related]
4. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
[TBL] [Abstract][Full Text] [Related]
5. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.
Bégué RE; Perrin K
Pediatrics; 2010 Jul; 126(1):e40-5. PubMed ID: 20587671
[TBL] [Abstract][Full Text] [Related]
6. Is rotavirus still a major cause for diarrheal illness in hospitalized pediatric patients after rotavirus vaccine introduction in the Saudi national immunization program?
Hegazi MA; Sayed MH; Sindi HH; Bekhit OE; El-Deek BS; Alshoudri FMY; Noorelahi AK
Medicine (Baltimore); 2017 Apr; 96(15):e6574. PubMed ID: 28403085
[TBL] [Abstract][Full Text] [Related]
7. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
[TBL] [Abstract][Full Text] [Related]
8. Rotavirus vaccination and short-term risk of adverse events in US infants.
Layton JB; Butler AM; Panozzo CA; Brookhart MA
Paediatr Perinat Epidemiol; 2018 Sep; 32(5):448-457. PubMed ID: 30048564
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus vaccination compliance and completion in a Medicaid infant population.
Krishnarajah G; Landsman-Blumberg P; Eynullayeva E
Vaccine; 2015 Jan; 33(3):479-86. PubMed ID: 24962753
[TBL] [Abstract][Full Text] [Related]
10. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community.
Muhsen K; Chodick G; Goren S; Shalev V; Cohen D
Vaccine; 2010 Dec; 29(1):91-4. PubMed ID: 20969927
[TBL] [Abstract][Full Text] [Related]
11. Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance.
Calnan M; Krishnarajah G; Duh MS; Haider BA; Yermakov S; Davis M; Yan S
Hum Vaccin Immunother; 2016 May; 12(5):1235-43. PubMed ID: 26900728
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.
Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C
Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493
[TBL] [Abstract][Full Text] [Related]
13. Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.
Giaquinto C; Dominiak-Felden G; Van Damme P; Myint TT; Maldonado YA; Spoulou V; Mast TC; Staat MA
Hum Vaccin; 2011 Jul; 7(7):734-48. PubMed ID: 21734466
[TBL] [Abstract][Full Text] [Related]
14. Public health impact of Rotarix vaccination among commercially insured children in the United States.
Krishnarajah G; Kageleiry A; Korves C; Lefebvre P; Duh MS
Vaccine; 2017 Sep; 35(37):5065-5072. PubMed ID: 28778611
[TBL] [Abstract][Full Text] [Related]
15. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan.
Harris V; Ali A; Fuentes S; Korpela K; Kazi M; Tate J; Parashar U; Wiersinga WJ; Giaquinto C; de Weerth C; de Vos WM
Gut Microbes; 2018 Mar; 9(2):93-101. PubMed ID: 28891751
[TBL] [Abstract][Full Text] [Related]
16. Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana.
Harris VC; Armah G; Fuentes S; Korpela KE; Parashar U; Victor JC; Tate J; de Weerth C; Giaquinto C; Wiersinga WJ; Lewis KD; de Vos WM
J Infect Dis; 2017 Jan; 215(1):34-41. PubMed ID: 27803175
[TBL] [Abstract][Full Text] [Related]
17. Public Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States.
Krishnarajah G; Duh MS; Korves C; Demissie K
PLoS One; 2016; 11(1):e0145977. PubMed ID: 26751375
[TBL] [Abstract][Full Text] [Related]
18. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
[TBL] [Abstract][Full Text] [Related]
19. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
[TBL] [Abstract][Full Text] [Related]
20. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
